Biologics and Biosimilars: Federal Policies and Patient Access

$ 0.00

Biologics and Biosimilars: Federal Policies and Patient Access

Following the 1-hour program,
participants will be able to:

  • Recognize how federal policies relate to approval, naming and interchangeability. 

  • Identify common barriers to patient access.

Expert presenters:

  • Dennis Cryer, MD – Convener, Biologics Prescribers Collaborative
  • Gavin Clingham, JD – Director of Public Policy, Alliance for Patient Access
  • David Charles, MD – Founder, Alliance for Patient Access & co-covener, Biologics Prescribers Collaborative

Moderated By:

  • Dennis Cryer, MD – Convener, Biologics Prescribers Collaborative